Manufacturer record
Swiss Garnier Life sciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
16 batches manufactured by Swiss Garnier Life sciences (Himachal Pradesh) were declared Not of Standard Quality between August 2023 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
16 records linked to Swiss Garnier Life sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 40 mg | 493TTF004Mfg 2025-07 · Exp 2027-06 | The sample does not conform to IP standards. If fails the test Dissolution as per IPDissolution | DTL, TVPMState lab | Jul 2026 |
| Telmisartan Tablets IP 40 mg | 493TTF014Mfg 2025-08 · Exp 2027-07 | The sample does not conform to IP standards. It fails the test Dissolution as per IPDissolution | DTL, TVPMState lab | Jul 2026 |
| Telmisartan Tablets IP 40 mg | 493TTF009Mfg 2025-08 · Exp 2027-07 | The sample does not conform to IP standards with respect to the test Dissolution.Dissolution | RDTL, ErnakulamState lab | Jun 2026 |
| Gliclazide & Metformin hydrochloride sustained release tablets | 475TGC002Mfg 2026-01 · Exp 2027-12 | ContentOther | DTL, Madurai-19State lab | May 2026 |
| Telmisartan Tablets IP 40mg | 493TTF011Mfg 2025-08 · Exp 2027-07 | Dissolution as per IPDissolution | DTL, KonniState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | 493TTF019Mfg 2025-08 · Exp 2027-07 | The sample fails the test 'Dissolution' as per IPDissolution | DTL ThrissurState lab | Mar 2026 |
| Telmisartan Tablets IP 40mg | 493TTF022Mfg 2025-08 · Exp 2027-07 | Sample fails the test Dissolution as per IP, specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Telmisartan Tablets IP 40mg | 493TTF015Mfg 2025-08 · Exp 2027-07 | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Telmisartan Tablets IP 40mg | 493TTF012Mfg 2025-08 · Exp 2027-07 | Sample fails the test Dissolution mentioned in the Laboratory Protocol as per IP.Dissolution | DTL KonniState lab | Feb 2026 |
| Telmisartan Tablets IP 40MG | 493TTF008Mfg 2025-07 · Exp 2027-06 | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Metformin Hydrochloride (ER) and Glimepiride Tablets IP | 244TGT008Mfg 2025-06 · Exp 2027-05 | Assay for GlimepirideAssay | RDTL, Bellary, KarnatakaState lab | Jan 2026 |
| Telmisartan Tablets IP 40mg | 493TTF020Mfg 2025-08 · Exp 2027-07 | Sample fails the test Dissolution.Dissolution | RDTL Ernakulam,KeralaState lab | Dec 2025 |
| Telmisartan Tablets IP 40mg | 251TTF025Mfg 2024-12 · Exp 2027-11 | DissolutionDissolution | RDTL, GuwahatiCDSCO lab | May 2025 |
| Telmisartan Tablets IP 40 mg | 251TTF036Mfg 2024-12 · Exp 2026-11 | DissolutionDissolution | RDTL, GuwahatiCDSCO lab | May 2025 |
| Telmisartan Tablets IP 40mg | 251TTF014Mfg 2024-08 · Exp 2026-07 | DissolutionDissolution | RDTL, GuwahatiCDSCO lab | Mar 2025 |
| Aspirin Gastro-resistant and Atorvastatin Capsules IP (75mg/10mg) | 54CAT09 6Mfg 2022-09 · Exp 2024-08 | Dissolution (buffer stage) of Aspirin and The Assay of Atrovastatin Calcium calculated as AtorvastatinAssay | RDTL ChandigarhCDSCO lab | Aug 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.